372 related articles for article (PubMed ID: 29089168)
1. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
[TBL] [Abstract][Full Text] [Related]
2. Geostatistical modelling of arsenic in drinking water wells and related toenail arsenic concentrations across Nova Scotia, Canada.
Dummer TJ; Yu ZM; Nauta L; Murimboh JD; Parker L
Sci Total Environ; 2015 Feb; 505():1248-58. PubMed ID: 24613511
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
[TBL] [Abstract][Full Text] [Related]
4. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
Saint-Jacques N; Parker L; Brown P; Dummer TJ
Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
[TBL] [Abstract][Full Text] [Related]
5. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
6. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
7. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.
Kurttio P; Pukkala E; Kahelin H; Auvinen A; Pekkanen J
Environ Health Perspect; 1999 Sep; 107(9):705-10. PubMed ID: 10464069
[TBL] [Abstract][Full Text] [Related]
8. Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.
Saint-Jacques N; Lee JSW; Brown P; Stafford J; Parker L; Dummer TJB
BMC Public Health; 2016 Feb; 16():175. PubMed ID: 26895703
[TBL] [Abstract][Full Text] [Related]
9. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
10. [Studies on markers of exposure and early effect in areas with arsenic pollution: methods and results of the project SEpiAs. Epidemiological studies on population exposed to low-to-moderate arsenic concentration in drinking water].
Bustaffa E; Bianchi F
Epidemiol Prev; 2014; 38(3-4 Suppl 1):14-24. PubMed ID: 25115551
[TBL] [Abstract][Full Text] [Related]
11. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
Chiou HY; Chiou ST; Hsu YH; Chou YL; Tseng CH; Wei ML; Chen CJ
Am J Epidemiol; 2001 Mar; 153(5):411-8. PubMed ID: 11226969
[TBL] [Abstract][Full Text] [Related]
12. Cancer risks from arsenic in drinking water.
Smith AH; Hopenhayn-Rich C; Bates MN; Goeden HM; Hertz-Picciotto I; Duggan HM; Wood R; Kosnett MJ; Smith MT
Environ Health Perspect; 1992 Jul; 97():259-67. PubMed ID: 1396465
[TBL] [Abstract][Full Text] [Related]
13. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
14. Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia.
Chappells H; Campbell N; Drage J; Fernandez CV; Parker L; Dummer TJ
Sci Total Environ; 2015 Feb; 505():1259-73. PubMed ID: 24444512
[TBL] [Abstract][Full Text] [Related]
15. [Accumulated Health Risk Assessment of Arsenic in Drinking Water of Major Cities of China].
Zhang QQ; Pan SL; Liu W; Zhang Y; An W
Huan Jing Ke Xue; 2017 May; 38(5):1835-1841. PubMed ID: 29965087
[TBL] [Abstract][Full Text] [Related]
16. Spatial Analysis of Human Health Risk Due to Arsenic Exposure through Drinking Groundwater in Taiwan's Pingtung Plain.
Liang CP; Chien YC; Jang CS; Chen CF; Chen JS
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28098817
[TBL] [Abstract][Full Text] [Related]
17. Low-level arsenic in drinking water and risk of incident myocardial infarction: A cohort study.
Monrad M; Ersbøll AK; Sørensen M; Baastrup R; Hansen B; Gammelmark A; Tjønneland A; Overvad K; Raaschou-Nielsen O
Environ Res; 2017 Apr; 154():318-324. PubMed ID: 28157645
[TBL] [Abstract][Full Text] [Related]
18. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
Karagas MR; Tosteson TD; Blum J; Morris JS; Baron JA; Klaue B
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491
[TBL] [Abstract][Full Text] [Related]
19. Estimating water supply arsenic levels in the New England Bladder Cancer Study.
Nuckols JR; Freeman LE; Lubin JH; Airola MS; Baris D; Ayotte JD; Taylor A; Paulu C; Karagas MR; Colt J; Ward MH; Huang AT; Bress W; Cherala S; Silverman DT; Cantor KP
Environ Health Perspect; 2011 Sep; 119(9):1279-85. PubMed ID: 21421449
[TBL] [Abstract][Full Text] [Related]
20. Nitrate in drinking water and bladder cancer risk in Spain.
Espejo-Herrera N; Cantor KP; Malats N; Silverman DT; Tardón A; García-Closas R; Serra C; Kogevinas M; Villanueva CM
Environ Res; 2015 Feb; 137():299-307. PubMed ID: 25601732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
